You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Waldenstrom's Disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Waldenstrom's Disease, Prognostic Index Trial in France

Not yet recruiting
  • Waldenstrom's Disease
  • Prognostic Index
    • Amiens, France
    • +14 more
    Jun 12, 2023

    Waldenstrom Macroglobulinemia, Waldenstrom's Disease, Waldenström; Hypergammaglobulinemia Trial in New York (Ibrutinib,

    Recruiting
    • Waldenstrom Macroglobulinemia
    • +6 more
    • New York, New York
      Weill Cornell Medicine
    Dec 21, 2021

    Clinical, Laboratory and Epidemiologic Characterization of

    Recruiting
    • Waldenstrom Macroglobulinemia
    • +4 more
      • Bethesda, Maryland
      • +1 more
      Jan 25, 2023

      Cancer Prevention, Weight Loss, Smoldering Waldenstrom Macroglobulinemia(WM) Trial in Boston (Prolonged Fasting Intervention,

      Not yet recruiting
      • Cancer Prevention
      • +5 more
      • Prolonged Fasting Intervention
      • EDUCATION CONTROL
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Dec 28, 2022

      Waldenstrom's Disease, Waldenstrom Macroglobulinemia Trial in Amiens (bone marrow sample, blood sample)

      Recruiting
      • Waldenstrom's Disease
      • Waldenstrom Macroglobulinemia
      • bone marrow sample
      • blood sample
      • Amiens, France
        CHU Amiens
      May 17, 2021

      MRD and Clonal Evolution in Waldenström's Macroglobulinemia and

      Active, not recruiting
      • Waldenstrom Macroglobulinemia
      • MRD and clonal evolution
      • Milano, MI, Italy
      • +13 more
      Nov 2, 2022

      Asymptomatic COVID-19 Infection Laboratory-Confirmed, B-Cell Tumor, Chronic Lymphocytic Leukemia Trial in Rochester (Ibrutinib,

      Withdrawn
      • Asymptomatic COVID-19 Infection Laboratory-Confirmed
      • +8 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Aug 2, 2022

      Melanoma, NSCLC, Breast Cancer Trial in United States (CDX-1140, CDX-301, Pembrolizumab)

      Completed
      • Melanoma
      • +25 more
      • Scottsdale, Arizona
      • +10 more
      Sep 27, 2022

      IgA Monoclonal Gammopathy, IgG Monoclonal Gammopathy, IgM Monoclonal Gammopathy Trial in Atlanta (Rifaximin)

      Recruiting
      • IgA Monoclonal Gammopathy
      • +8 more
      • Atlanta, Georgia
        Emory University Hospital/Winship Cancer Institute
      Oct 18, 2021

      Waldenstrom's Disease Trial in Rouen (Determination of mutation)

      Unknown status
      • Waldenstrom's Disease
      • Determination of mutation
      • Rouen, France
        Centre Henri Becquerel
      Jul 29, 2020

      Grade 3a Follicular Lymphoma, Recurrent Burkitt Lymphoma, Recurrent DLBCL Trial in Atlanta, Columbus (other, drug, biological)

      Recruiting
      • Grade 3a Follicular Lymphoma
      • +14 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Atlanta, Georgia
      • +1 more
      May 31, 2022

      Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

      Active, not recruiting
      • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +36 more
      • Buffalo, New York
        Roswell Park Cancer Institute
      Jan 23, 2023

      Lymphoplasmacytic Lymphoma, Waldenstrom Macroglobulinemia Trial in United States (Ibrutinib, Rituximab, Venetoclax)

      Suspended
      • Lymphoplasmacytic Lymphoma
      • Waldenstrom Macroglobulinemia
      • Centralia, Illinois
      • +73 more
      Jul 27, 2022

      Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Aurora, Seattle (drug, procedure,

      Active, not recruiting
      • Acute Biphenotypic Leukemia
      • +18 more
      • Aurora, Colorado
      • +2 more
      Dec 28, 2022

      Waldenstrom Macroglobulinemia Trial in China (Ibrutinib)

      Active, not recruiting
      • Waldenstrom Macroglobulinemia
      • Changchun, China
      • +5 more
      Jan 27, 2023

      Immune Responses to COVID-19 Vaccination in Lymphoma Patients

      Active, not recruiting
      • Classical Hodgkin Lymphoma
      • +12 more
        • Bedford, Bedfordshire, United Kingdom
        • +8 more
        Feb 22, 2022

        Waldenstrom Macroglobulinemia Trial in Japan (Ibrutinib, Rituximab)

        Active, not recruiting
        Has Results
        • Waldenstrom Macroglobulinemia
        • Chiba, Japan
        • +8 more
        Jan 27, 2023

        Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug, biological, radiation)

        Recruiting
        • Acute Leukemia
        • +18 more
        • Allogeneic Hematopoietic Stem Cell Transplantation
        • +8 more
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        Oct 26, 2022

        Waldenstrom's Macroglobulinemia Trial in Boston (Ibrutinib)

        Completed
        Has Results
        • Waldenstrom's Macroglobulinemia
        • Boston, Massachusetts
        • +1 more
        Dec 5, 2022

        Waldenstrom's Macroglobulinemia Trial in Boston (Ulocuplumab, Ibrutinib)

        Active, not recruiting
        • Waldenstrom's Macroglobulinemia
        • Boston, Massachusetts
          Dana Farber Cancer Institute
        Jun 20, 2022

        Waldenstrom Macroglobulinemia Trial in Canada (Acalabrutinib, Bendamustine, Rituximab)

        Recruiting
        • Waldenstrom Macroglobulinemia
        • Calgary, Alberta, Canada
        • +8 more
        Nov 9, 2022

        Waldenstrom's Macroglobulinemia Trial in Houston (Bortezomib, Rituximab, Valacyclovir)

        Active, not recruiting
        Has Results
        • Waldenstrom's Macroglobulinemia
        • Houston, Texas
          University of Texas MD Anderson Cancer Center
        Dec 5, 2022

        Waldenstrom Macroglobulinemia, MYD88 Gene Mutation Trial in Boston (IBRUTINIB, Venetoclax)

        Active, not recruiting
        • Waldenstrom Macroglobulinemia
        • MYD88 Gene Mutation
        • Boston, Massachusetts
        • +1 more
        Apr 1, 2022

        Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

        Completed
        Has Results
        • Adult Nasal Type Extranodal NK/T-cell Lymphoma
        • +18 more
        • Scottsdale, Arizona
        • +1 more
        Sep 28, 2020

        Lymphoma Trial in Houston (2CdA, Cyclophosphamide, Rituximab)

        Completed
        • Lymphoma
        • Houston, Texas
          University of Texas MD Anderson Cancer Center
        Mar 3, 2022